SMTL ID : 8cx9.1 (3 other biounits)

Structure of the SARS-COV2 PLpro (C111S) in complex with a dimeric Ubv that inhibits activity by an unusual allosteric mechanism

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.50 Å

Oligo State

hetero-1-2-mer

Ligands

1 x ZN: ZINC ION(Non-covalent)

ZN.1: 4 residues within 4Å: Chain A: C.194, C.197, C.229, C.231 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:C.194, A:C.197, A:C.229, A:C.231

2 x BR: BROMIDE ION(Non-covalent)

BR.2: 3 residues within 4Å: Chain A: G.232, K.233, Q.234 Ligand excluded by PLIP BR.3: 3 residues within 4Å: Chain B: G.72, M.73, L.74 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

van Vliet, V.J.E. et al., Ubiquitin variants potently inhibit SARS-CoV-2 PLpro and viral replication via a novel site distal to the protease active site. Plos Pathog. (2022)

Release Date

2023-01-25

Peptides

Papain-like protease nsp3: A
Ubiquitin variant UbV.CV2.1: BC

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

B
F

C
G

Papain-like protease nsp3

Ubiquitin variant UbV.CV2.1

Related Entries With Identical Sequence